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Introduction  
In the last decade the incidence of ectopic 
pregnancy (EP) had an increasing trend. EP 
is seen in 6 -16% of women in reproductive                                              
age (1). The early diagnosis of this condition 
is so important. 3D vaginal Doppler 
ultrasonography with ßHCG test has 
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provided a rapid diagnosis of this condition 
(2).  
The supportive treatment for EP along with 
laparoscopy is improving and caused a rapid 
treatment. The supportive surgery for 
detaching the trophoblastic from 
endosalpinx, because of its high risk is so 
difficult which can cause salpingectomy (3). 
In most cases, the surgery can be prevented 
with medical therapy and follow up, with all 
of this, some patients are not good 
candidates for medical treatment and the 
surgery is the treatment of choice.   
Hagenius and colleagues reported their 
results of an interventional study as an 
unsuccessful conservative therapy in the 
cases of EP and the need for intervention in 
most cases of this condition (4) the effect of 
oxytocin is not clearly understood in the 
studies. Oxytocin shows two phenomenons, 
first, it causes salpinx contractions, as the 
contractions in the myometrium. Second, it 
can produce a vasoconstriction in 
mesosalpinx artery (5).  
In the study of Fedel and colleagues on the 
effect of the injection of 20 units of 
Oxytocin to mesosalpinx in laparoscopy, it 
is concluded that oxytocin improves the 
surgical treatment. With regard to the 
importance of bleeding and the reserve of 
urethral tubes, the need for intensive studies 
is felt (1).  
Salpingectomy is the most common surgery 
for ectopic pregnancy. This option is chosen 
for torn urethral tubes, but in cases with torn 
urethral tubes, the conservative surgical 
methods such as salpingectomy and 
segmental resection are chosen. Surgery can 
be done in both laparoscopic and laparatomy 
methods. The recommended surgical 
method for the unruptured EP is the linear 
salpingectomy. A longitudinal tear is made 
on the anti-mesenteric surface on the 
prominent mass using cutter, laser or scissor 
and the products are evicted using forceps or 
irrigation. The using of diluted vasopressin 
(1 unit/1 ml) or oxytocin (20 units) injection 
to the mesosalpinx can reduce the number of 
electro cutters needed for hemostasis. 
Incision can be kept open or can be closed, 
the long term reproductive results are equal 
in both methods (6).  
The conservative management of EP is 
improved due to the early diagnosis of the 
disease, but in conservative surgery, the 
detachment of trophoblastic from the 
endosalpinx can causes severe bleeding and 
results in the salpingectomy. The linear 
salpingectomy is successful in about 80% of 
cases and in the rest of cases , the bleeding 
can lead to the tubectomy or in some cases 
the surgeon may use intensive coagulation 
which the aim of conservative is not 
achieved leading to relapse of EP(3).  
In the past, vasoconstrictors such as 
Adrenalin and Vasopressin was used in 
controlling the bleeding (7) but was 
abandoned due to the systemic 
complications (8). Based on the known 
constrictor effects of Oxytocin on the 
urethra, Fedele and colleagues have studied 
its effects on the muscular fibers of salpinx 
in women with tubal pregnancy and showed 
that the intra mesosalpinx injection of 
oxytocin can accelerate the conservative 
surgery of EP (1) but since the sample size 
of this study was limited the study on 
reproductive prognosis of this methods had 
been suggested. The aim of this study is the 
evaluation of the topical oxytocin as a 
supportive treatment in conservative 
treatment in patients with EP who 
underwent open or laparoscopic surgery 
with diagnosis of unruptured EP. In this 
study, we evaluated the effect of oxytocin 
plus normal saline in controlling the 
 163
bleeding during and after the salpingectomy 
and reserving the urethral tubes and 
compared with the cases which were 
received the normal saline alone. The 
primary outcome criteria included the 
control of bleeding during the 
salpingectomy and the ease of eviction of 
pregnancy products and the need for change 
the procedure to the salpingectomy the  
secondary outcome is Tube patency 2 
months after surgery.   
Methods and Materials  
In a clinical trial in the Department of 
Obstetrics and gynecology, in Tabriz 
University of Medical Sciences, Center for 
Research on Women's reproductive health in 
women with ruptured ectopic pregnancy the 
effect the oxytocin injection in mesosalpinx 
in reserving the urethral tubes in the 
surgeries of unruptured ectopic pregnancy 
was investigated.  
During the year 2012, 67 patients with 
ectopic pregnancy were enrolled into the 
study they were randomly divided into two 
groups.  
67 women who were diagnosed with 
unruptured ectopic pregnancy by 
laparoscopy or laparotomy were enrolled. 
Patients were divided into two groups: the 
first group received 20 units oxytocin 
diluted in 20 ml saline that was injected in 
mesosalpinx under the ectopic pregnancy 
and the second group received normal saline 
only.  
3 min after injection was salpingectomy was 
tried and the pregnancy products were 
evicted. Amount of blood loss during 
surgery, requiring removal of the tube due to 
the severity of bleeding, coagulation times 
were noted. Based on the amount, bleeding 
severity was scored (mild - moderate and 
severe). (3 = abundant, 2 = moderate, 1 = 
minimal). Bleeding at the site of pregnancy, 
as well as the ease of removal of the 
products of pregnancy was scored. (Difficult 
= 3, moderately difficult = 2 easy = 1), and 
require of the conversion of surgery to 
salpingectomy was investigated. ßHCG 
levels were measured before surgery, after 
surgery and then every 3 days until the 
ßHCG measurements were negative. 
Preoperative hematocrit levels were 
measured 6 hours after surgery. Two months 
later, all patients were treated and the 
degrees of openness of the fallopian tube 
were recorded.  
Statistical analysis  
Data were entered into statistical software 
Spss 17.0. The statistical test, Chi-square, 
Man-Whitney U, X2 and T-test was used for 
statistical analysis with P <0.05 was 
considered statistically significant.  
Ethical considerations   
For all patients who entered the study, 
written informed consent has been obtained 
after giving the necessary information and 
the effects and consequences of the acts 
described to patients in the language 
understandable.  
Results and Discussion  
In this study, 67 patients with EP with and 
without Intramesosalpingeal injection of 
oxytocin have been treated and the 
following results were: 
The mean gestational age in patients treated 
with and without Intramesosalpingeal 
injection of oxytocin were 5.4± 1-07 and 
5,34±1.37 weeks respectively (P=0.835). 
Mean baseline ßHCG levels in patients 
treated with and without 
Intramesosalpingeal injection of oxytocin 
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were 3811.78±4173±72 and 7581.91± 
14184.96 respectively (P=0.141). Mean 
baseline hematocrit in patients treated with 
and without Intramesosalpingeal injection of 
oxytocin were  and 32.6±3.59 
respectively (P=0.192). Mean HCG level 
after 1 day of surgery in patients treated with 
and without Intramesosalpingeal injection of 
oxytocin were 2560.77± 2991.40 and 
3426.38±5020.05 IU / ml respectively 
(P=0.413). The mean hematocrit at 6 hours 
after surgery in patients treated with and 
without Intramesosalpingeal injection of 
oxytocin were 30.12±2.53 and 28.62.3,54 
percent (P=0.053). The mean rate of 
reduction in ßHCG in the day after surgery 
in patients treated with and without 
Intramesosalpingeal injection were 
1234.25±2686.87 and 2177.19±1069.02 
respectively (P=0.636).  
The amount of bleeding during surgery in 17 
patients (5 patients treated without 
Intramesosalpingeal injection of oxytocin 
and 12 patients treated with injections of 
oxytocin Intramesosalpingeal) were mild, in 
43 patients (24 patients treated without 
Intramesosalpingeal injections of oxytocin 
and 19 patients treated with 
Intramesosalpingeal injections of oxytocin) 
were moderate and in 7 patients (6 patients 
treated without injection of oxytocin and 1 
patient treated with oxytocin) was severe.  
The rate of intraoperative bleeding in 
patients treated with Intramesosalpingeal 
injection of oxytocin was significantly less 
than intraoperative bleeding in patients 
treated without injection of oxytocin 
(P=0.01).  
Ease of removal of the products of ectopic 
pregnancy in 17 patients (4 patients without 
Intramesosalpingeal injection of oxytocin 
and 13 patients treated with 
Intramesosalpingeal injection of oxytocin) 
was Easy, in 40 patients (22 patients treated 
with Intramesosalpingeal injection of 
oxytocin and 18 patients treated with 
Intramesosalpingeal injection of oxytocin) 
was  moderate and in 10 patients (9 patients 
treated without Intramesosalpingeal 
injection of oxytocin and 1 patients treated 
with Intramesosalpingeal injection of 
oxytocin) was difficult.  
Ease of removal of the products of ectopic 
pregnancy in patients treated with 
Intramesosalpingeal injection of oxytocin 
was significantly easier  compared to 
patients treated without Intramesosalpingeal 
injection of oxytocin (P=0.001 ).  
Number of times of cutter using for 
controlling the intraoperative bleeding in 6 
patients treated with Intramesosalpingeal  
injection of oxytocin was low (less than 3 
times), in 52 patients (28 patients treated 
with Intramesosalpingeal  injection of 
oxytocin, 24 patients received no injection 
of oxytocin) was moderate (6-4 times) and 
in 9 patients (7 patients treated without 
Intramesosalpingeal injection of oxytocin 
and 2 patients treated with 
Intramesosalpingeal  injection of oxytocin) 
were high (more The six-time respectively). 
Number of times of cutter using for 
controlling the intraoperative bleeding in 
patients treated with Intramesosalpingeal 
injection of oxytocin was significantly lower 
than the frequency of times of cutter using 
for controlling the intraoperative bleeding in 
patients without injection of oxytocin 
(P=0.005 ).  
Need to remove the tube during surgery in 
23 patients (20 patients treated without 
Intramesosalpingeal injection of oxytocin 
and 3 patients treated with 
Intramesosalpingeal injection of oxytocin) 
was present. Need to remove of the tube 
during surgery in patients treated without 
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Intramesosalpingeal injection of oxytocin 
was significantly more than the numbers to 
remove the tube during surgery in patients 
treated with Intramesosalpingeal injection of 
oxytocin (P<0.001)  
The fallopian tubes at 2 months 
postoperatively in 26 patients (5 patients 
treated without Intramesosalpingeal 
injection of oxytocin and 21 patients treated 
with Intramesosalpingeal injection of 
oxytocin) was open and in 18 patients (10 
patients treated with Intramesosalpingeal 
injection of oxytocin and 8 patients treated 
with Intramesosalpingeal injection of 
oxytocin) was closed. The evaluation was 
not possible in 23 patients due to surgical 
removal of the tube. Patency of the fallopian 
tubes in patients treated with 
Intramesosalpingeal injection of oxytocin at 
2 months after surgery, was significantly 
more than patients treated without 
Intramesosalpingeal injection of oxytocin 
(P=0.021).  
EP is one of the most common emergencies 
in obstetrics and gynecology and is one of 
the first differential diagnosis of acute 
abdomen in women of reproductive age (9). 
Treatment of ectopic pregnancy depends not 
only on the patient's age and desire for 
future pregnancy, but also depends on 
gestational age of patients during 
laparoscopic findings (10). Obviously, the 
older patient with no intention for the next 
pregnancy, the treatment of choice is a 
simple method of salpingectomy using laser, 
cutter or 3 rings (5 loop method) (11). 
Conservative surgery for ectopic pregnancy 
is associated with risk of recurrence and that 
is the fact that the patient and her family 
should be informed (12-14).  
Incidence rate:  
Given the evidence recorded in the 
hospitals, the incidence of ectopic pregnancy 
is rising steadily, so that the incidence has 
reached from 4.5 per 1000 in 1970 to 16.8 
per 1000 in 1992.  
Direct injection of cytotoxic drugs, injection 
of prostaglandins, hyperosmolar glucose, 
potassium chloride and saline to the place of 
EP as an alternative to Methotrexate is 
pending. In these methods, the success rate 
is low and needs to have a laparoscopic or 
vaginal aspirations are practically 
unavoidable. Delivery to the site of ectopic 
pregnancy Methotrexate via hysteroscopy is 
also under study (1).  
In this study, the effect mesosalpinx 
injection of oxytocin in on treatment of EP 
and decrease of bleeding and reduce in tubal 
resection was investigated.  
We may fail In the MTX treatment. Severe 
enduring pain, declining hematocrit, 
orthostatic hypotension.  Rapid diagnosis 
and surgical treatment in most cases will 
prevent the EP from rupture. Nowadays 
laparatomy and laparoscopy with 
salpingectomy is the first treatment of 
choice for ruptured ectopic pregnancy. 
Almost all patients with hypovolemic shock 
due to rupture of the EP are in need of blood 
transfusions. If Laparoscopist is expert 
enough as well as cardiac monitoring and 
anesthesia for laparoscopic salpingectomy is 
appropriate alternative if Methotrexate is 
contraindicated is.  
EP rate of relapse is slightly higher after 
conservative surgery. In following cases 
laparoscopic salpingectomy is preferred on 
Salpingostomy: the uncontrollable bleeding 
untreatable conservatively. Extensive 
damage to the tubes, recurrence EP in the 
same tube, linear Salpingostomy with 
surgical sterilization is the surgical method 
conservatively recommended for the EP. In 
a study by Laatikainen and colleagues 
conducted on patients with tubal EP, The 
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Effect of osmolar glucose topical infusion 
during surgery was evaluated, they stated 
that reduction of ßHCG in patients with 
osmolar glucose infusion and patients with 
Salpingostomy alone were 37% and 53%, 
respectively (15). In our study the rate of the 
post operative reduction in ßHCG in patients 
with injection of oxytocin was 21.36±27.26 
%.  
In a study by Stock et al conducted on 
patients with EP, The Effect of Vasopressin 
on infusion during surgery of EP was 
studied. They reported that vasopressin is 
effective in controlling bleeding and 
hemostasis in patients, but there was no 
significant difference in hematocrit levels in 
patients with and without injection of 
vasopressin (16).  
In our study, the mean hematocrit at 6 hours 
after surgery in patients treated without 
Intramesosalpingeal injection of oxytocin 
was  28.62±3.54 and in patients treated with 
Intramesosalpingeal infusion of oxytocin 
was 30.12±2.53 there was no significant 
difference between hematocrit at 6 hours 
after surgery in patients treated with and 
without injection of oxytocin (P=0.053), but 
the amount of bleeding during surgery in 
patients treated with Intramesosalpingeal 
injection of oxytocin was significantly less 
than intraoperative bleeding in patients 
treated with Intramesosalpingeal injection of 
oxytocin I (P=0.001).  
In a study by Porpora et al on patients with 
EP, the effect of topical Methotrexate with 
linear Salpingostomy was evaluated and it 
was concluded that the rate of ßHCG 
normalization and the patency of fallopian 
tubes is equal in both methods (17). In our 
study like the study above, there was not a 
significant difference between the mean 
reduction rate of ßHCG level in the day after 
the surgery in patients with and without 
Intramesosalpingeal oxytocin (P=0.636). 
But the eviction of pregnancy products was 
easier in patients with Intramesosalpingeal 
oxytocin injection (P=0.001) the need for 
tubectomy in patients receiving 
Intramesosalpingeal oxytocin was 
significantly lower than patients not 
receiving Intramesosalpingeal oxytocin 
(P<0.001).  
Zilber and colleagues had carried out a study 
on the patients with EP and evaluated the 
laparoscopic Salpingostomy with topical 
Methotrexate on patients with unruptured 
EP; they concluded that the normalization 
time for ßHCG is equal in both methods 
(18). In another study by Moon et al on 
patients with EP, the effect of injection of 
vasopressin during the surgery was studied 
on patients with a mean age of 33.5 years 
and mean gestational age of 6.7 weeks; they 
reported this method as a safe method which 
can decrease the risk of bleeding during the 
surgery (19).  
In our study the times of using of cutter for 
controlling the bleeding in the patients 
receiving Intramesosalpingeal oxytocin was 
significantly lower that the times of cutter 
use in patients not receiving the 
Intramesosalpingeal oxytocin (P=0.005).and 
the patency of fallopian tubes in the patients 
who underwent the injection of 
Intramesosalpingeal oxytocin was 
significantly higher 2 months after the 
surgery comparing the patients who did not 
receive Intramesosalpingeal oxytocin 
(P=0.012)  
Conclusion  
The results show that the intra mesosalpinx 
injection of oxytocin in patients with 
unruptured EP can reduce the bleeding 
increase the ease of evicting the pregnancy 
products and reduce the tubal resection. The 
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patency of fallopian tubes in patients with 
Intramesosalpingeal injection of oxytocin 
had been increased meaningfully 2 month 
after the surgery. So this method is 
recommended in surgeries with tubal 
reserve. 
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